Hyperion Therapeutics, Inc. is a commercial-stage biopharmaceutical company committed to advancing science and developing life-changing treatments for orphan and hepatic diseases.
View all »Recent Releases
May 16, 2013
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI)
May 9, 2013
Hyperion Therapeutics Announces First Quarter 2013 Operating Results
View all »Events & Presentations
Jun 3, 2013
Jefferies 2013 Global Healthcare Conference
Category:
Delicious
Digg
Facebook
LinkedIn
Twitter
Yahoo! Buzz